scholarly article | Q13442814 |
P50 | author | Breno Satler Diniz | Q38800234 |
Marcia Radanovic | Q45289063 | ||
Paula Villela Nunes | Q47378254 | ||
Monica S Yassuda | Q64498850 | ||
Orestes V Forlenza | Q91970111 | ||
Danilo T Borelli | Q117261113 | ||
P2093 | author name string | Izabella D Abreu | |
P2860 | cites work | A rating scale for depression | Q24564540 |
“Mini-mental state” | Q25938989 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
Current concepts in mild cognitive impairment | Q34104314 | ||
Evaluation of a mental test score for assessment of mental impairment in the elderly | Q34216117 | ||
Cerebral blood flow in dementia | Q34518886 | ||
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment | Q35868499 | ||
Guaranteed stimulus-processing in the evaluation of memory and learning | Q38501742 | ||
CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination | Q44456828 | ||
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. | Q45194604 | ||
Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia | Q47643386 | ||
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG. | Q50664830 | ||
CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. | Q51041842 | ||
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
Mini-mental State Examination performance in mild cognitive impairment subtypes. | Q51903669 | ||
Screening for mild cognitive impairment in elderly ambulatory patients with cognitive complaints. | Q51922680 | ||
The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. | Q51924667 | ||
The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. | Q51985663 | ||
CAMDEX, can it be more efficient? Observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team. | Q52021789 | ||
A short screening instrument for poststroke dementia : the R-CAMCOG. | Q52026030 | ||
Clock drawing in Alzheimer's disease. A novel measure of dementia severity. | Q52064819 | ||
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. | Q52077039 | ||
MCI is a clinically useful concept. | Q53380350 | ||
[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease | Q60451990 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mild cognitive impairment | Q1472703 |
dementia | Q83030 | ||
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 1127-1133 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | International Journal of Geriatric Psychiatry | Q6051406 |
P1476 | title | CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. | |
P478 | volume | 23 |
Q42662164 | A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints |
Q34021001 | Application study of quick cognitive screening test in identifying mild cognitive impairment |
Q37407597 | Applications of technology in neuropsychological assessment |
Q51847162 | Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education? |
Q50607336 | Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work? |
Q37389846 | Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. |
Q33795233 | Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination? |
Q46964545 | Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. |
Q51030241 | Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors |
Q51135677 | Diagnostic transitions in mild cognitive impairment subtypes. |
Q37022147 | Feasibility and validity of dementia assessment by trained community health workers based on Clinical Dementia Rating |
Q34600572 | Internet-based screening for dementia risk |
Q50652639 | Is the Cambridge Cognitive Examination - revised a good tool for detection of dementia in illiterate Brazilian older adults? |
Q37582563 | Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review |
Q49031432 | Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study |
Q38125621 | Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. |
Q51873283 | Mild cognitive impairment: cognitive screening or neuropsychological assessment? |
Q47146178 | Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil |
Q51043584 | Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. |
Q48912689 | Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? |
Q48745229 | Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up |
Q51782041 | Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. |
Q47378206 | Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil |
Q55514334 | Qualitative analysis and identification of pattern of errors in Clock Drawing Tests of community-dwelling older adults. |
Q48092158 | Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study |
Q48329873 | Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. |
Q46119787 | Specific algorithm method of scoring the Clock Drawing Test applied in cognitively normal elderly. |
Q86325537 | Spectral analyses of systolic blood pressure and heart rate variability and their association with cognitive performance in elderly hypertensive subjects |
Q51871520 | The Clock Drawing Test--Modified and Integrated Approach (CDT-MIA) as an instrument for detecting mild cognitive impairment in a specialized outpatient setting. |
Q37611114 | The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds. |
Q37764258 | The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review |
Q47812130 | Validation of the Six-Item Screener to screen for cognitive impairment in primary care settings in China |
Q38380106 | Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education |